Sumitomo Pharma America, Inc.
Sunovion is a global biopharmaceutical company whose spirit of innovation is driven by the conviction that scientific excellence paired with meaningful advocacy and relevant education can improve lives. Sunovion’s vision is to lead the way to a healthier world. With patients at the center of everything it does, Sunovion has charted new paths to life-transforming treatments for people with serious psychiatric, neurological and respiratory conditions. For more information, visit Sunovion.com.